Sabra Health (Germany) Performance
| SBC Stock | EUR 17.88 0.05 0.28% |
On a scale of 0 to 100, Sabra Health holds a performance score of 12. The entity has a beta of 0.0754, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sabra Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sabra Health is expected to be smaller as well. Please check Sabra Health's coefficient of variation, jensen alpha, and the relationship between the downside deviation and information ratio , to make a quick decision on whether Sabra Health's existing price patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Sabra Health Care are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Sabra Health reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 115.9 M |
Sabra |
Sabra Health Relative Risk vs. Return Landscape
If you would invest 1,502 in Sabra Health Care on August 31, 2024 and sell it today you would earn a total of 286.00 from holding Sabra Health Care or generate 19.04% return on investment over 90 days. Sabra Health Care is currently producing 0.2887% returns and takes up 1.7999% volatility of returns over 90 trading days. Put another way, 16% of traded stocks are less volatile than Sabra, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Sabra Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sabra Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sabra Health Care, and traders can use it to determine the average amount a Sabra Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1604
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SBC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.8 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Sabra Health is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sabra Health by adding it to a well-diversified portfolio.
Sabra Health Fundamentals Growth
Sabra Stock prices reflect investors' perceptions of the future prospects and financial health of Sabra Health, and Sabra Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sabra Stock performance.
| Return On Equity | -0.0241 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 5.1 B | |||
| Shares Outstanding | 231.16 M | |||
| Price To Earning | 25.24 X | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 6.70 X | |||
| Revenue | 624.81 M | |||
| EBITDA | 216.89 M | |||
| Cash And Equivalents | 56.81 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 2.31 B | |||
| Debt To Equity | 106.60 % | |||
| Book Value Per Share | 13.23 X | |||
| Cash Flow From Operations | 315.73 M | |||
| Earnings Per Share | (0.33) X | |||
| Total Asset | 5.75 B | |||
About Sabra Health Performance
By analyzing Sabra Health's fundamental ratios, stakeholders can gain valuable insights into Sabra Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sabra Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sabra Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
As of March 31, 2019, Sabras investment portfolio included 437 real estate properties held for investment 304 Skilled NursingTransitional Care facilities, 88 Senior Housing communities , 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements and 22 Specialty Hospitals and Other facilities, 30 assets held for sale, one investment in a direct financing lease, 20 investments in loans receivable one mortgage loan, two construction loans and 17 other loans, nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing Managed communities. As of March 31, 2019, Sabras real estate properties held for investment included 43,884 bedsunits and its unconsolidated joint venture included 7,652 bedsunits, spread across the United States and CanadaThings to note about Sabra Health Care performance evaluation
Checking the ongoing alerts about Sabra Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sabra Health Care help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sabra Health Care has high likelihood to experience some financial distress in the next 2 years | |
| Sabra Health Care has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 624.81 M. Net Loss for the year was (77.61 M) with profit before overhead, payroll, taxes, and interest of 372.8 M. | |
| Over 90.0% of the company shares are owned by institutional investors |
- Analyzing Sabra Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sabra Health's stock is overvalued or undervalued compared to its peers.
- Examining Sabra Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sabra Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sabra Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sabra Health's stock. These opinions can provide insight into Sabra Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sabra Stock analysis
When running Sabra Health's price analysis, check to measure Sabra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Health is operating at the current time. Most of Sabra Health's value examination focuses on studying past and present price action to predict the probability of Sabra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Health's price. Additionally, you may evaluate how the addition of Sabra Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |